Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    " September 19, 2012":" October 19, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" September 19, 2012":" October 19, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Comparison of Two IUDs Among Cape Town HIV-positive Women
Condition: HIV
Interventions: Device: Mirena levonorgestrel IUD;   Device: Copper T-380a IUD
2 Completed Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera
Condition: HIV-1 Infection
Intervention:
3 Active, not recruiting
Has Results
Safety and Efficacy of E/C/F/TDF (Stribild®) Versus RTV-Boosted ATV Plus FTC/TDF (Truvada®) in HIV-1 Infected, Antiretroviral Treatment-Naive Women
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: E/C/F/TDF;   Drug: RTV;   Drug: ATV;   Drug: FTC/TDF;   Drug: E/C/F/TDF Placebo;   Drug: RTV Placebo;   Drug: ATV Placebo;   Drug: FTC/TDF Placebo;   Drug: E/C/F/TAF
4 Completed Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult MC Programs in Zimbabwe
Conditions: Circumcision Adult;   HIV CDC Category B2;   HIV Infections
Intervention: Device: PrePex™ device
5 Completed Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: SeV-G(NP) (0.2mL, 2x10^7 CIU);   Biological: SeV-G(NP) (0.2mL, 2x10^8 CIU);   Biological: Ad35-GRIN (0.5mL)
6 Completed Immune Reconstitution in HIV Disease (IREHIV)
Condition: HIV Infection
Interventions: Drug: vitamin D (cholecalciferol) and PBA (sodium phenylbutyrate);   Drug: Placebo tablets
7 Completed First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers
Condition: HIV
Interventions: Drug: Maraviroc;   Drug: TVD 300/200 QD
8 Completed CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)
Condition: Human Immunodeficiency Virus
Interventions: Device: Intervention Arm (computer-based CARE+ Corrections tool);   Other: Educational video on opiate overdose prevention
9 Withdrawn A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection
Condition: Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Intervention: Drug: No intervention
10 Recruiting Brain Imaging for HIV-Associated Thinking and Mood Disorders
Conditions: Human Immunodeficiency Virus;   Neurocognitive Impairment
Intervention:
11 Active, not recruiting A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment
Condition: Human Immunodeficiency Virus-type 1 Infection
Interventions: Drug: Rilpivirine;   Drug: Efavirenz;   Drug: Tenofovir disoproxil fumarate;   Drug: Emtricitabine
12 Unknown  A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection
Conditions: Infection;   HIV
Intervention: Drug: Truvada and Isentress
13 Active, not recruiting Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet
Condition: HIV
Intervention: Drug: (FDC) ELV/COBI/FTC/TDF
14 Active, not recruiting Network Supported Engagement In HIV Care
Conditions: HIV;   Patient Acceptance of Health Care
Intervention: Other: Supportive Care
15 Unknown  Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen
Conditions: HIV;   Hypercholesterolemia;   Dyslipidemia
Intervention:
16 Completed HOPE (Harnessing Online Peer Education): Using Online Social Networks for HIV Prevention and Testing
Condition: HIV
Intervention: Behavioral: HIV knowledge Intervention
17 Unknown  Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz
Conditions: Hyperlipidemia;   HIV
Interventions: Drug: Pitavastatin;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Efavirenz
18 Completed Benefits and Costs of Integrating Sexual-Reproductive Health and HIV Services in Kenya and Swaziland
Conditions: Pregnancy;   HIV
Intervention: Procedure: Integrated FP/PNC service delivery
19 Completed HIV Prevention for Injecting Drug Users in Kazakhstan
Conditions: HIV;   AIDS
Interventions: Behavioral: Couples Based HIV/STI Risk Reduction Intervention (CHSR);   Behavioral: Renaissance Wellness Promotion (WP)
20 Completed Comparing the PrePex™ Device to Surgical MC for Rapid Scale Up of MC in Resource Limited Setting
Condition: HIV
Interventions: Device: PrePex™ device for adult male circumcision;   Procedure: Surgical circumcision

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years